NCT06214702Completed
Serpin C and Soluble Fms-like Tyrosine Kinase-1 Levels in Normotensive Pregnant Women May Predict the Development of Preeclampsia
Deregulated Serum Levels of Serpin C and Soluble Fms-like Tyrosine Kinase-1 Might Predict the Development of Preeclampsia in Normotensive Pregnant Women
Source: ClinicalTrials.gov · Last updated 22 Jan 2024
Brief summary (registry, in English)
Evaluation of the predictability of estimated levels of Serpin C, sFlt-1 and placental growth factor (PLGF) in blood samples obtained during the 1st trimester from normotensive pregnant women for identification of women liable to develop PE during the course of pregnancy.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 60 (actual)
- First submitted
- 10 Jan 2024
- Start date
- 7 Jan 2023
- Primary completion date
- 12 May 2023
- Lead sponsor
- Benha University
- NCT number
- NCT06214702
What you commit to
- Study type: Observational
- Participants enrolled: 60
- From 7 Jan 2023 to the primary completion date, 12 May 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Hypertension
Age
- Age
Other
- Sex
Who the study is looking for
- Normotensive pregnant women had singleton fetus presenting during the 1st trimester
- free of exclusion criteria
Age in the registry: 25 years to 45 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Banha University Coordinator of this site? Confirm its status | Banhā | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.